INDIA-EU FTA unlocks access to $572.3 billion EU pharmaceuticals & medical devices market
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
Growth across inorganic & organic chemicals, fertilisers, pharmaceuticals, cosmetics, soaps and detergents
The deal brings Labcorp’s U.S. portfolio—including biocompatibility, microbiological, and analytical testing, as well as preclinical research—under NAMSA’s roof
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The new site marks the company’s first operation in the region
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The company’s largest center for medical device applications, serving the entire Asian market
Viatel bioresorbable polymers are increasingly used in dental and orthopedic implants
Subscribe To Our Newsletter & Stay Updated